Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer.
about
Oxaliplatin-DNA adduct formation in white blood cells of cancer patientsPersonalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.Conjunctive therapy of cisplatin with the OCT2 inhibitor cimetidine: influence on antitumor efficacy and systemic clearanceCisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
P2860
Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@ast
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@en
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@nl
type
label
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@ast
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@en
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@nl
prefLabel
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@ast
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@en
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@nl
P2093
P1433
P1476
Adaptive intrapatient dose esc ...... advanced head and neck cancer.
@en
P2093
Maliepaard M
Planting AS
Schellens JH
de Boer Dennert M
P304
P356
10.1097/00001813-200109000-00004
P577
2001-09-01T00:00:00Z